BARBARA A. MCAULIFFE, Magistrate Judge.
This stipulation in the above-captioned matter is made by and between the attorneys for Plaintiffs Brenda Sears and Robert Sears ("Plaintiffs") and Defendants Bristol-Myers Squibb Company, Otsuka Pharmaceutical Co., Ltd., and Otsuka America Pharmaceutical, Inc. (collectively "Defendants").
IT IS HEREBY STIPULATED AND AGREED, by and between the attorneys for the parties hereto, that the prescribed time within which Defendants may move, answer, or otherwise respond to the Complaint is hereby extended by 30 days, and that Plaintiffs will have an additional 30 days from the time prescribed by the applicable rules to respond to any motion filed by Defendants in response to the Complaint.
This is the parties' first request for an extension. All parties agree to this extension, and the extension does not affect any other previously scheduled dates.
IT IS SO STIPULATED.
IT IS SO ORDERED THAT the Defendants Bristol-Myers Squibb Company, Otsuka Pharmaceutical Co., Ltd., and Otsuka America Pharmaceutical, Inc. (collectively "Defendants") will have an additional 30 days from the time returned Summons for the Defendants (Docs. 11, 12 and 13), respond to any motion filed by Defendants in response to the Complaint is due by March 17, 2016.